These data suggest that Th17 and Th22 cells may share similar pathways and activation environment during the HT pathogenesis and CD4+IFN-γ−IL-17A+IL-22+ T cells may be intermeddlers of differentiated Th17 and Th22. The gene discussed is IL22; the disease is hematocrit.